Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Glycomimetics Inc. | 3 | 6 | 0 | 3 | €0.15 | €9.13 | 5909.605% |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Cara Therapeutics Inc. | 10 | 6 | 0 | 2 | €0.31 | €4.61 | 1375.320% |
| Viking Therapeutics Inc | 5 | 1 | 0 | 1 | €57.22 | - | - |
| Pacific Biosciences of California Inc. | 10 | 4 | 1 | 0 | €1.27 | €9.20 | 624.209% |
| Organovo Holdings Inc. | 0 | 8 | 0 | 0 | €0.54 | - | - |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.22 | €7.31 | 127.384% |
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | €0.71 | €5.49 | 673.732% |
| T2 Biosystems Inc. | 0 | 4 | 0 | 0 | €0.16 | - | - |
| Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | €1.27 | - | - |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 0 | €2.48 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.39 | - | - |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 88.568% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.11 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.04 | €50.00 | 4693.864% |
| Syros Pharmaceuticals Inc. | 9 | 1 | 3 | 0 | €1.51 | €12.01 | 695.066% |
| Natural Alternat. | 19 | 1 | 0 | 0 | €4.74 | - | - |
| Novan Inc | 0 | 20 | 0 | 0 | €0.001 | - | - |
| Edap Tms S.A. ADR | 5 | 1 | 1 | 0 | €2.80 | €17.46 | 523.607% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Aspira Womens Health Inc. | 1 | 1 | 1 | 0 | €0.86 | €4.99 | 483.906% |